Abstract

Cyclic adenosine 5′-diphosphate ribose (cADPR) is an emerging Ca2+-mobilising second messenger. cADPR analogues have been generated as chemical biology tools via both chemo-enzymatic and total synthetic routes. Both routes rely on the cyclisation of a linear precursor to close an 18-membered macrocyclic ring. We show here that, after cyclisation, there are two possible macrocyclic product conformers that may be formed, depending on whether cyclisation occurs to the “right” or the “left” of the adenine base (as viewed along the H-8 → C-8 base axis). Molecular modelling demonstrates that these two conformers are distinct and cannot interconvert. The two conformers would present a different spatial layout of binding partners to the cADPR receptor/binding site. For chemo-enzymatically generated analogues Aplysia californica ADP-ribosyl cyclase acts as a template to generate solely the “right-handed” conformer and this corresponds to that of the natural messenger, as originally explored using crystallography. However, for a total synthetic analogue it is theoretically possible to generate either product, or a mixture, from a given linear precursor. Cyclisation on either face of the adenine base is broadly illustrated by the first chemical synthesis of the two enantiomers of a “southern” ribose-simplified cIDPR analogue 8-Br-N9-butyl-cIDPR, a cADPR analogue containing only one chiral sugar in the “northern” ribose, i.e. 8-Br-D- and its mirror image 8-Br-L-N9-butyl-cIDPR. By replacing the D-ribose with the unnatural L-ribose sugar, cyclisation of the linear precursor with pyrophosphate closure generates a cyclised product spectroscopically identical, but displaying equal and opposite specific rotation. These findings have implications for cADPR analogue design, synthesis and activity.

Highlights

  • Cyclic adenosine 5′-diphosphate ribose is a cyclic dinucleotide that is produced enzymatically from nicotinamide adenine dinucleotide (NAD+, 2) by ADP-ribosyl cyclases CD38 and CD157 in humans (Fig. 1)[1]

  • We previously studied the role of the “southern” ribose conformation in activity at the sea urchin Cyclic adenosine 5′-diphosphate ribose (cADPR) receptor[7], and a recent detailed NMR study has analysed both ribose conformations in four cADPR analogues that were prepared via the chemo-enzymatic route[8]

  • The crystal structure of cADPR24 and the co-crystal structures of cIDPR with CD3811 and Aplysia californica ADP ribosyl cyclase[25] all show a cyclic ligand conformation where the phosphates are located to the “right” of the purine base, when the base is orientated arbitrarily so that H-8 → C-8 is in the foreground, with H-8 pointing towards the viewer and the 6-NH2 or C=O respectively points upwards

Read more

Summary

Introduction

Cyclic adenosine 5′-diphosphate ribose (cADPR, 1) is a cyclic dinucleotide that is produced enzymatically from nicotinamide adenine dinucleotide (NAD+, 2) by ADP-ribosyl cyclases CD38 and CD157 in humans (Fig. 1)[1]. The main drawback of the chemo-enzymatic route is its reliance on recognition of an NAD+ derivative as a substrate by Aplysia californica ADP-ribosyl cyclase and the correct orientation of that substrate in the active site[16]. In such a synthesis of cIDPR (6), an 8-bromo-NAD+ analogue (8-Br-NHD+, 4) was required to generate N1-cIDPR (6) (without this 8-Br substitution, cyclisation proceeds to give the regioisomeric, fluorescent, but biologically-inactive N7-cIDPR)[13,14,17]. The material prepared by total synthesis was spectroscopically identical to that obtained via the chemo-enzymatic route

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.